Trial Profile
A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Spinal cord disorders
- Focus Therapeutic Use
- 14 Sep 2016 Status changed from recruiting to discontinued.
- 10 Apr 2015 New trial record